Managing metabolic syndrome typically involves making lifestyle changes to address the underlying risk factors
Important safety information Get prescribed by a licensed provider today
Kobayashi, T., Usui, H., Tanaka, H
Staying consistent with daily dosing through this period is essential
When specific GLP-1 RAs were evaluated compared to placebo and other antidiabetic drugs, liraglutide was found to increase risk of thyroid disorders by 37% and dulaglutide in similar comparisons increased risk by 96%
ALAD: Amino levulinic acid dehydratase Current Treatment Strategy for Lead Toxicity Chelation Treatment [32] Some common chelating agents used against lead poisoning are given below: Calcium disodium ethylene diamine tetraacetic acid (CaNa 2 EDTA) D-penicillamine Meso 2,3-dimercaptosuccinic acid (DMSA) Sodium 2,3-dimercaptopropane-1-sulphonate (DMPS) Limitations of Current Chelating Agents Treatment with DMSA and DMPS has got lesser adverse effects given in [Table/Fig-6]